RHHBY obtains FDA approval for Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.

A new breast cancer drug has received quick federal approval after a clinical trial showed it could more than double the time before a common type of breast cancer recurrence worsens.

H.C. Wainwright analyst Robert Burns reiterated a Buy rating on Relay Therapeutics (RLAY – Research Report) today and set a price target ...

In a report released yesterday, Luisa Hector from Berenberg Bank maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), ...

A 49-year-old man was arrested at a security checkpoint near Trump's Coachella rally on Saturday. 'The world is on fire, and I’m not that interested in laundry-folding content,' the 'Succession ...

Inside the dangerous world of Russian front-line soldiers working as double agents for the enemy ...

"I’ve done 60 Minutes many times, even back in the good ol’ days when Journalism was respected and legit, but I have never seen a very poor answer being REPLACED by another, totally ...

Stage 1 of the GRAP, a set of winter-specific anti-pollution measures, focuses on controlling pollution through dust mitigation at construction sites, proper waste management, and regular road ...

Daron Acemoglu, Simon Johnson and James Robinson won the 2024 Nobel economics prize "for studies of how institutions are formed and affect prosperity", the Royal Swedish Academy of Sciences said ...

The world's biggest snake, a previously unknown species of giant anaconda, was discovered recently in an Amazon rainforest. With a length of up to 7.5 meters and a weight of nearly 500 kilograms, this ...